An investigation of the mechanisms underlying the proteasome inhibitor bortezomib resistance in PC3 prostate cancer cell line
A Yerlikaya, E Okur - Cytotechnology, 2020 - Springer
The phenomenon of acquired resistance to chemotherapeutic agents is a long-standing
conundrum in cancer treatment. To help delineate drug resistance mechanisms and pave …
conundrum in cancer treatment. To help delineate drug resistance mechanisms and pave …
An investigation of the mechanisms underlying the proteasome inhibitor bortezomib resistance in PC3 prostate cancer cell line
A Yerlikaya, E Okur - Cytotechnology, 2020 - pubmed.ncbi.nlm.nih.gov
The phenomenon of acquired resistance to chemotherapeutic agents is a long-standing
conundrum in cancer treatment. To help delineate drug resistance mechanisms and pave …
conundrum in cancer treatment. To help delineate drug resistance mechanisms and pave …
An investigation of the mechanisms underlying the proteasome inhibitor bortezomib resistance in PC3 prostate cancer cell line
A Yerlikaya, E Okur - Cytotechnology, 2020 - search.proquest.com
The phenomenon of acquired resistance to chemotherapeutic agents is a long-standing
conundrum in cancer treatment. To help delineate drug resistance mechanisms and pave …
conundrum in cancer treatment. To help delineate drug resistance mechanisms and pave …
An investigation of the mechanisms underlying the proteasome inhibitor bortezomib resistance in PC3 prostate cancer cell line
A Yerlikaya, E Okur - CYTOTECHNOLOGY, 2020 - avesis.ksbu.edu.tr
The phenomenon of acquired resistance to chemotherapeutic agents is a long-standing
conundrum in cancer treatment. To help delineate drug resistance mechanisms and pave …
conundrum in cancer treatment. To help delineate drug resistance mechanisms and pave …
An investigation of the mechanisms underlying the proteasome inhibitor bortezomib resistance in PC3 prostate cancer cell line.
A Yerlikaya, E Okur - Cytotechnology, 2019 - europepmc.org
The phenomenon of acquired resistance to chemotherapeutic agents is a long-standing
conundrum in cancer treatment. To help delineate drug resistance mechanisms and pave …
conundrum in cancer treatment. To help delineate drug resistance mechanisms and pave …
[HTML][HTML] An investigation of the mechanisms underlying the proteasome inhibitor bortezomib resistance in PC3 prostate cancer cell line
A Yerlikaya, E Okur - Cytotechnology, 2020 - ncbi.nlm.nih.gov
The phenomenon of acquired resistance to chemotherapeutic agents is a long-standing
conundrum in cancer treatment. To help delineate drug resistance mechanisms and pave …
conundrum in cancer treatment. To help delineate drug resistance mechanisms and pave …